<DOC>
	<DOCNO>NCT00337402</DOCNO>
	<brief_summary>Results effect symptomatic treatment QoL appear conflict ALS patient . Moreover clear effect gastrotomy show survival . Prospective study effect tube feeding , QoL survival perform 17 teach hospital France ( observational study )</brief_summary>
	<brief_title>Effects Gastrostomy Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>Following data record three month : QoL ( MOS-SF 36 ALSAQ ) , bodily mass index , test ALS-FRS scale , functional respiratory measure , impedance analysis , time tube feed procedure , condition acceptance side-effects gastrotomy</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>patient &gt; 18 yearsold ALS certain probable vital capacity ( respiratory ) &gt; 70 % riluzole ALS family condition affect survival QoL cognitive impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Gastrostomy</keyword>
	<keyword>Quality life</keyword>
</DOC>